Latest News about ABBV
Recent news which mentions ABBV
From Motley Fool
Amgen Lifts Annual Outlook After Q3 Performance, But Stock Still Falls - Here's Why
October 31, 2023
From Benzinga
Why AbbVie Stock Was a Winner on Monday
October 30, 2023
From Motley Fool
AbbVie Analysts Increase Their Forecasts After Upbeat Earnings
October 30, 2023
Tickers
ABBV
From Benzinga
2 No-Brainer Dividend Stocks to Buy This Week
October 30, 2023
From Motley Fool
From Benzinga
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
October 27, 2023
From Benzinga
AbbVie Raises Annual Profit Outlook As Newer Immunology Drugs Help Cushion Struggling Humira Sales
October 27, 2023
Tickers
ABBV
From Benzinga
AbbVie results beat expectations despite low-cost competition to blockbuster Humira
October 27, 2023
From MarketWatch
Earnings Scheduled For October 27, 2023
October 27, 2023
From Benzinga
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
October 26, 2023
From Motley Fool
The 7 Best Forever Stocks to Buy for October 2023
October 25, 2023
From InvestorPlace
Investor Risk Sentiment Wavers Amid War, Interest Rate Concerns; Tesla Earnings Disappoint: The Week In The Markets
October 20, 2023
From Benzinga
7 Dividend Stocks to Buy and Hold Forever and Ever
October 20, 2023
From InvestorPlace
7 Dividend Aristocrats to Batten Down the Hatches
October 19, 2023
From InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
October 19, 2023
From Motley Fool
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
October 18, 2023
Tickers
ABBV
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
